The following are mergers under review by the European Commission and a brief guide to the EU merger process: APPROVALS AND WITHDRAWALS-- Generic drugmaker Mylan Inc to purchase Abbot Laboratories' specialty and branded generics business outside the United States (approved Jan. 28)-- Swiss drugmaker Novartis to acquire British peer GlaxoSmithKline's oncology products (approved Jan. 28)
Mylan Inc. (Mylan) is a global pharmaceutical company, which develops, licenses, manufactures, markets and distributes generic, branded generic and specialty pharmaceuticals. Shares of MYL traded higher by 0.02% or $0.01/share to $56.30. In the past year, the shares have traded as low as $42.43 and as high as $59.60. On average, 3331340 shares of MYL exchange hands on a given day and today's volume is recorded at 1808305.
Source
